Tenders/DENOSUMAB INJ 60MG/ 1 ML
Open🇯🇴JordanSupplies

DENOSUMAB INJ 60MG/ 1 ML

وزارة الصحة
Published: Nov 15, 2026
Updated: Nov 15, 2026
Source: JONEPS Jordan

About This Opportunity

This is a supplies contract in the general supplies and health and medical services sectors, with a focus on Pharmaceuticals. Located in Jordan, Middle East & North Africa, this opportunity is open to firms and consortiums.

Published through JONEPS Jordan, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the general supplies sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. Interested parties should review the full documentation on the original source before submitting their proposal.

Description

This tender, originating from the Hashemite Kingdom of Jordan, is for the procurement of Denosumab injections, specifically at a dosage of 60 mg per 1 ml. Denosumab is a monoclonal antibody used to treat conditions such as osteoporosis and bone metastases from cancer. This procurement is for a specialized biologic medication essential for patient treatment protocols. The tender will demand suppliers to provide Denosumab injections that meet rigorous pharmaceutical quality and regulatory standards. Key requirements will include the precise dosage (60 mg/ml), presentation (e.g., single-use pre-filled syringe), packaging, expiry dating, and specific storage requirements, which typically involve refrigeration to maintain product integrity. Bidders must demonstrate the authenticity and quality of the product, providing necessary documentation such as regulatory approvals, manufacturing site details, and proof of adherence to cold chain logistics. The evaluation process will focus on the product's compliance with all technical and regulatory specifications, the supplier's capacity for reliable and secure delivery, and the overall economic offer, ensuring patients receive this vital therapeutic agent.

Data provenance

This notice is sourced from JONEPS Jordan and was originally published on November 15, 2026. Last refreshed today. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About وزارة الصحة

وزارة الصحة has issued 2,665 procurement notices on BidsFactory, including 86 currently open and 0 awarded contracts. Activity concentrates in Health & Medical, General Supplies & Services, and Construction & Civil Works. All notices are published for Jordan. Notices are distributed via JONEPS Jordan. Most recent publication: November 15, 2026.

Frequently asked questions about this tender

Where will the contract be performed?

The contract is for delivery in Jordan. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.

How can I submit a bid?

Visit JONEPS Jordan to access the full notice, required documents, and submission instructions provided by the contracting authority.

Who is the contracting authority?

This notice was issued by وزارة الصحة in Jordan. The authority is responsible for evaluating bids, awarding the contract, and managing performance.

What type of contract is this?

This is a Supplies contract in the General Supplies & Services sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

Find tenders like this automatically

Premium shows the full details of every tender like this one and alerts you instantly when a new one is published.

See plans

Key Details

Contract Type
Supplies
Eligibility
Firms / Consortiums
Language
English

Source

joneps_jo
JONEPS Jordan
Public Procurement

Contracting Authority

وزارة الصحة
🇯🇴Jordan